Retrospective study of Parkinson's Disease Psychosis patients treated with Pimavanserin.
Phase of Trial: Phase IV
Latest Information Update: 07 May 2018
At a glance
- Drugs Pimavanserin (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 07 May 2018 New trial record
- 27 Apr 2018 Results (n=59) presented at the 70th Annual Meeting of the American Academy of Neurology
- 27 Apr 2018 According to the ACADIA Pharmaceuticals media release, Researchers at Vanderbilt University Medical Center performed this study.